Clinical Trial Update: Imlifidase for Highly Sensitized Kidney Transplant Recipients With a posItive crossmAtch Against a Deceased Donor: Results of Kidney Transplantations Performed in Accordance to the French Guidelines.

View source ↗

Summary

Clinical trial update on the use of imlifidase to enable kidney transplantation in highly sensitized recipients with a positive crossmatch from a deceased donor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Imlifidase (imlifidase)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Kidney Transplantation | Status: NOT_YET_RECRUITING